Complexity of the 5′UTR region of the CLCN5 gene: eleven 5′UTR ends are differentially expressed in the human kidney

BMC Medical Genomics

Franca Anglani³  John C Lieske²  Alessandra Familiari³  Leonardo Salviati¹  Alberto Casarin¹  Enrica Tosetto³ 

[1] Clinical Genetics Unit, Department of Pediatrics, University of Padova, Padova, Italy;Department of Internal Medicine, Division of Nephrology and Hypertension, and Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA;Laboratory of Histomorphology and Molecular Biology of the Kidney, Department of Medicine DIMED, University of Padova, via Giustiniani, 2, 35128 Padova, (PD), Italy

关键词: Gene expression;    mRNA variant;    5’UTR isoforms;    CLCN5 gene;    Dent disease;   

Others  :  1090881
DOI  :  10.1186/1755-8794-7-41

 received in 2013-12-10, accepted in 2014-06-24,  发布年份 2014

【 摘 要 】

Background

Dent disease 1 represents a hereditary disorder of renal tubular epithelial function associated with mutations in the CLCN5 gene that encoded the ClC-5 Cl^-/H⁺ antiporter. All of the reported disease-causing mutations are localized in the coding region except for one recently identified in the 5’UTR region of a single patient. This finding highlighted the possible role for genetic variability in this region in the pathogenesis of Dent disease 1.

The structural complexity of the CLCN5 5’UTR region has not yet been fully characterized. To date 6 different 5’ alternatively used exons - 1a, 1b, 1b1 and I-IV with an alternatively spliced exon II (IIa, IIb) - have been described, but their significance and differential expression in the human kidney have not been investigated. Therefore our aim was to better characterize the CLCN5 5’UTR region in the human kidney and other tissues.

Methods

To clone more of the 5’ end portion of the human CLCN5 cDNA, total human kidney RNA was utilized as template and RNA ligase-mediated rapid amplification of cDNA 5’ ends was applied.

The expression of the different CLCN5 isoforms was studied in the kidney, leucocytes and in different tissues by quantitative comparative RT/PCR and Real -Time RT/PCR.

Results

Eleven transcripts initiating at 3 different nucleotide positions having 3 distinct promoters of varying strength were identified. Previously identified 5’UTR isoforms were confirmed, but their ends were extended. Six additional 5’UTR ends characterized by the presence of new untranslated exons (c, V and VI) were also identified. Exon c originates exon c.1 by alternative splicing. The kidney uniquely expresses all isoforms, and the isoform containing exon c appears kidney specific. The most abundant isoforms contain exon 1a, exon IIa and exons 1b1 and c. ORF analysis predicts that all isoforms except 3 encode for the canonical 746 amino acid ClC-5 protein.

Conclusions

Our results confirm the structural complexity of the CLCN5 5’UTR region. Characterization of this crucial region could allow a clear genetic classification of a greater number of Dent disease patients, but also provide the basis for highlighting some as yet unexplored functions of the ClC-5 proton exchanger.

【 授权许可】

   
2014 Tosetto et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 10.

【 参考文献 】

• [1]Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, Rigden SP, Wrong O, Jentsch TJ, Craig IW, Thakker RV: A common molecular basis for three inherited kidney stone diseases. Nature 1996, 379(6564):445-449.
• [2]Hayama A, Uchida S, Sasaki S, Marumo F: Isolation and characterization of the human CLC-5 chloride channel gene promoter. Gene 2000, 261:355-364.
• [3]Fisher SE, Van Bakel I, Lloyd SE, Pearce SHS, Thakker RV, Craig IW: Cloning and characterization of CLCN5, the human kidney chloride channel gene implicated in Dent disease (an X-linked hereditary nephrolithiasis). Genomics 1995, 29(3):598-606.
• [4]Forino M, Graziotto R, Tosetto E, Gambaro G, D’Angelo A, Anglani F: Identification of a novel splice site mutation of CLCN5 gene and characterization of a new alternative 5′ UTR end of ClC-5 mRNA in human renal tissue and leukocytes. J Hum Genet 2004, 49(1):53-60.
• [5]Ludwig M, Waldegger S, Nuutinen M, Bökenkamp A, Reissinger A, Steckelbroeck S, Utsch B: Four additional CLCN5 exons encode a widely expressed novel long ClC-5 isoform but fail to explain Dent’s phenotype in patients without mutations in the short variant. Kidney Blood Press Res 2003, 26(3):176-184.
• [6]Akuta N, Lloyd SE, Igarashi T, Shiraga H, Matsuyama T, Yokoro S, Cox JP, Thakker RV: Mutations of CLCN5 in Japanese children with idiopathic low molecular weight proteinuria, hypercalciuria and nephrocalcinosis. Kidney Int 1997, 52:911-916.
• [7]Ludwig M, Doroszewicz J, Seyberth HW, Bökenkamp A, Balluch B, Nuutinen M, Utsch B, Waldegger S: Functional evaluation of Dent’s disease-causing mutations: implications for ClC-5 channel trafficking and internalization. Hum Genet 2005, 117:228-237.
• [8]Hoopes RR Jr, Raja KM, Koich A, Hueber P, Reid R, Knohl SJ, Scheinman SJ: Evidence for genetic heterogeneity in Dent’s disease. Kidney Int 2004, 65:1615-1620.
• [9]Tosetto E, Ghiggeri GM, Emma F, Barbano G, Carrea A, Vezzoli G, Torregrossa R, Cara M, Ripanti G, Ammenti A, Peruzzi L, Murer L, Ratsch IM, Citron L, Gambaro G, D’angelo A, Anglani F: Phenotypic and genetic heterogeneity in Dent’s disease–the results of an Italian collaborative study. Nephrol Dial Transplant 2006, 21(9):2452-2463.
• [10]Tosetto E, Ceol M, Mezzabotta F, Ammenti A, Peruzzi L, Caruso MR, Barbano G, Vezzoli G, Colussi G, Vergine G, Giordano M, Glorioso N, Degortes S, Soldati L, Sayer J, D’Angelo A, Anglani F: Novel mutations of the CLCN5 gene including a complex allele and A 5′ UTR mutation in Dent disease 1. Clin Genet 2009, 76(4):413-416.
• [11]Bökenkamp A, Böckenhauer D, Cheong HI, Hoppe B, Tasic V, Unwin R, Ludwig M: Dent-2 disease: a mild variant of Lowe syndrome. J Pediatr 2009, 155(1):94-99.
• [12]Del Prete D, Forino M, Gambaro G, D’Angelo A, Baggio B, Anglani F: A comparative kinetic RT/-PCR strategy for the quantitation of mRNAs in microdissected human renal biopsy specimens. Exp Nephrol 1998, 6(6):563-567.
• [13]Nolan T, Hands RE, Bustin SA: Quantification of mRNA using real-time RT-PCR. Nat Protoc 2006, 1(3):1559-1582.
• [14]Reese MG, Eeckman FH, Kulp D, Haussler D: Improved Splice Site Detection in Genie. J Comp Biol 1997, 4(3):311-323.
• [15]Brunak S, Engelbrecht J, Knudsen S: Prediction of Human mRNA Donor and Acceptor Sites from the DNA Sequence. J Mol Biol 1991, 220:49-65.
• [16]Allen JE, Salzberg SL: A phylogenetic generalized hidden Markov model for predicting alternatively spliced exons. Algorithms Mol Biol 2006, 1:14.
• [17]Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C: Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acid Res 2009, 37(9):e67.
• [18]Hofacker IL, Fontana W, Stadler PF, Bonhoeffer S, Tacker M, Schuster P: Fast Folding and Comparison of RNA Secondary Structures. Monatshefte f Chemie 1994, 125:167-188.
• [19]Zuker M, Stiegler P: Optimal computer folding of large RNA sequences using thermodynamic and auxiliary information. Nucl Acid Res 1981, 9:133-148.
• [20]ENCODE Project Consortium: The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 2004, 306:636-640.
• [21]Shapiro MB, Senapathy P: RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 1987, 15:7155-7174.
• [22]Tanaka K, Terryn S, Geffers L, Garbay S, Pontoglio M, Devuyst O: The transcription factor HNF1α regulates expression of chloride-proton exchanger ClC-5 in the renal proximal tubule. Am J Physiol Renal Physiol 2010, 299:F1339-F1347.
• [23]Koren E, Lev-Maor G, Ast G: The Emergence of Alternative 3′ and 5′ Splice Site Exons from Constitutive Exons. PLoS Comput Biol 2007, 3(5):e95.
• [24]Hiller M, Zhang Z, Backofen R, Stamm S: Pre-mRNA secondary structure influence exon recognition. Plos Genet 2007, 3(11):e204.
• [25]Zhang J, Kuo1 CCJ, Chen L: GC content around splice sites affects splicing through pre-mRNA secondary structures. BMC Genomics 2011, 12:90-100.
• [26]Steinmeyer K, Schwappach B, Bens M, Vandewalle A, Jentsch TJ: Cloning and functional expression of rat ClC-5 a chloride channel related to kidney disease. J Biol Chem 1995, 270:31172-31177.
• [27]Ramos Trujillo E, González Acosta H, Flores C, García Nieto V, Guillén E, Gracia S, Vicente C, Espinosa L, Maseda MA, Santos F, Camacho JA, Claverie Martín F: A missense mutation in the chloride/proton ClC-5 antiporter gene results in increased expression of an alternative mRNA form that lacks exons 10 and 11. Identification of seven new CLCN5 mutations in patients with Dent’s disease. J Hum Genet 2007, 52(3):255-261.
• [28]Addis M, Meloni C, Tosetto E, Ceol M, Cristofaro R, Melis MA, Vercelloni P, Del Prete D, Marra G, Anglani F: An atypical Dent’s disease phenotype caused by co-inheritance of mutations at CLCN5 and OCRL genes. Eur J Hum Genet 2003, 21(6):687-690.
• [29]Vandewalle A, Cluzeaud F, Peng KC, Bens M, Lüchow A, Günther W, Jentsch TJ: Tissue distribution and subcellular localization of the ClC-5 chloride channel in rat intestinal cells. Am J Physiol Cell Physiol 2001, 280(2):C373-C381.
• [30]Cornejo I, Niemeyer MI, Sepúlveda FV, Cid LP: Cloning, cellular distribution and functional expression of small intestinal epithelium guinea pig ClC-5 chloride channel. Biochim Biophys Acta 2001, 1512(2):367-374.
• [31]Luyckx VA, Leclercq B, Dowland LK, Yu AS: Diet-dependent hypercalciuria in transgenic mice with reduced CLC5 chloride channel expression. PNAS 1999, 96(21):12174-12179.
• [32]Na T, Zhang W, Peng JB: Chloride channel ClC-5 linked to Dent’s disease decreases protein level of the intestinal calcium entry channel TRPV6 in Xenopus oocytes (Abstract). FASEB J 2009, 23:998.15.
• [33]Wu G, Zhang W, Na T, Jing H, Wu H, Peng JB: Suppression of intestinal calcium entry channel TRPV6 by OCRL, a lipid phosphatase associated with Lowe syndrome and Dent disease. Am J Physiol Cell Physiol 2012, 302(10):C1479-C1491.
• [34]Chen H, Ruan YC, Xu WM, Chen J, Chan HC: Regulation of male fertility by CFTR and implications in male infertility. Hum Reprod Update 2012, 18(6):703-713.